Medicinal composition for promoting synthesis of protoporphyrin IX

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603928
APP PUB NO 20160136274A1
SERIAL NO

14898581

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The object of the present invention is to elucidate the resistance mechanism in infections that show resistance to ALA-PDT that uses a single ALA, and to provide a novel treatment method against these infections. The present invention provides a pharmaceutical composition for promoting protoporphyrin IX production in ALA-PDT for treating infection, characterized in that it comprises a substance that promotes the conversion from coproporphyrinogen III to protoporphyrin IX.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SBI PHARMACEUTICALS CO LTDTOKYO 106-6020

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ishizuka, Masahiro Tokyo, JP 37 315
Kamiya, Atsuko Tokyo, JP 2 0
Morimoto, Kuniyuki Osaka, JP 1 0
Oto, Urara Tokyo, JP 1 0
Ozawa, Toshiyuki Osaka, JP 39 644
Takahashi, Kiwamu Tokyo, JP 78 336
Tanaka, Tohru Tokyo, JP 88 464
Watanabe, Keitaro Tokyo, JP 7 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00